These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 21798425)

  • 21. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
    Krauser DG; Lloyd-Jones DM; Chae CU; Cameron R; Anwaruddin S; Baggish AL; Chen A; Tung R; Januzzi JL
    Am Heart J; 2005 Apr; 149(4):744-50. PubMed ID: 15990762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of growth hormone (GH) treatment on circulating Nt-proBNP concentrations and on cardiac function in adult GH-deficient patients.
    Gruson D; Alexopoulou O; Pasquet A; Cumps J; Ketelslegers JM; Maiter D
    Scand J Clin Lab Invest; 2012 Sep; 72(5):387-94. PubMed ID: 22794032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations of circulating natriuretic peptides with haemodynamics in precapillary pulmonary hypertension.
    Kaiser R; Grotemeyer K; Lepper P; Stokes C; Bals R; Wilkens H
    Respir Med; 2015 Sep; 109(9):1213-23. PubMed ID: 26194624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease.
    Eindhoven JA; van den Bosch AE; Ruys TP; Opić P; Cuypers JA; McGhie JS; Witsenburg M; Boersma E; Roos-Hesselink JW
    J Am Coll Cardiol; 2013 Sep; 62(13):1203-12. PubMed ID: 23916937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breed differences in natriuretic peptides in healthy dogs.
    Sjöstrand K; Wess G; Ljungvall I; Häggström J; Merveille AC; Wiberg M; Gouni V; Lundgren Willesen J; Hanås S; Lequarré AS; Mejer Sørensen L; Wolf J; Tiret L; Kierczak M; Forsberg S; McEntee K; Battaille G; Seppälä E; Lindblad-Toh K; Georges M; Lohi H; Chetboul V; Fredholm M; Höglund K
    J Vet Intern Med; 2014; 28(2):451-7. PubMed ID: 24495256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natriuretic peptide testing for the evaluation of critically ill patients with shock in the intensive care unit: a prospective cohort study.
    Januzzi JL; Morss A; Tung R; Pino R; Fifer MA; Thompson BT; Lee-Lewandrowski E
    Crit Care; 2006 Feb; 10(1):R37. PubMed ID: 16507171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in hemodialysis patients.
    Helal I; Belhadj R; Mohseni A; Bazdeh L; Drissa H; Elyounsi F; Abdallah TB; Abdelmoula J; Kheder A
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):262-8. PubMed ID: 20228511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of transdermal testosterone on natriuretic peptide levels in women: a randomized placebo-controlled pilot study.
    Lin E; McCabe E; Newton-Cheh C; Bloch K; Buys E; Wang T; Miller KK
    Fertil Steril; 2012 Feb; 97(2):489-93. PubMed ID: 22137497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-terminal pro-B-type natriuretic peptide in chronic heart failure: The impact of sex across the ejection fraction spectrum.
    Faxén UL; Lund LH; Orsini N; Strömberg A; Andersson DC; Linde C; Dahlström U; Savarese G
    Int J Cardiol; 2019 Jul; 287():66-72. PubMed ID: 31005415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary N-terminal pro-B-type natriuretic peptide as a biomarker for cardiovascular events in a general Japanese population: the Hisayama Study.
    Yamasaki K; Hata J; Ide T; Nagata T; Sakata S; Yoshida D; Honda T; Hirakawa Y; Nakano T; Kitazono T; Tsutsui H; Ninomiya T
    Environ Health Prev Med; 2021 Apr; 26(1):47. PubMed ID: 33845756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
    Bhatt AS; Cooper LB; Ambrosy AP; Clare RM; Coles A; Joyce E; Krishnamoorthy A; Butler J; Felker GM; Ezekowitz JA; Armstrong PW; Hernandez AF; O'Connor CM; Mentz RJ
    J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29431103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-terminal pro-B-type natriuretic peptide in early and advanced phases of obesity.
    Mangge H; Almer G; Zelzer S; Vasan R; Kraigher-Krainer E; Gasser R; Schnedl W; Ille R; Wallner S; Möller R; Horejsi R; Weghuber D
    Clin Chem Lab Med; 2011 Sep; 49(9):1539-45. PubMed ID: 21663466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumour necrosis factor {alpha} blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study.
    Peters MJ; Welsh P; McInnes IB; Wolbink G; Dijkmans BA; Sattar N; Nurmohamed MT
    Ann Rheum Dis; 2010 Jul; 69(7):1281-5. PubMed ID: 19934107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of midregional pro-A-type natriuretic peptide and the N-terminal pro-B-type natriuretic peptide for predicting mortality and cardiovascular events.
    van Hateren KJ; Alkhalaf A; Kleefstra N; Groenier KH; de Jong PE; de Zeeuw D; Gans RO; Struck J; Bilo HJ; Gansevoort RT; Bakker SJ
    Clin Chem; 2012 Jan; 58(1):293-7. PubMed ID: 21948291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population-based detection of systolic and diastolic dysfunction with amino-terminal pro-B-type natriuretic peptide.
    Abhayaratna WP; Marwick TH; Becker NG; Jeffery IM; McGill DA; Smith WT
    Am Heart J; 2006 Nov; 152(5):941-8. PubMed ID: 17070165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective evaluation of B-type natriuretic peptide concentrations and the risk of type 2 diabetes in women.
    Everett BM; Cook NR; Chasman DI; Magnone MC; Bobadilla M; Rifai N; Ridker PM; Pradhan AD
    Clin Chem; 2013 Mar; 59(3):557-65. PubMed ID: 23288489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender : Results from the PROBE-HF study.
    Ballo P; Betti I; Barchielli A; Balzi D; Castelli G; De Luca L; Gheorghiade M; Zuppiroli A
    Clin Res Cardiol; 2016 May; 105(5):421-31. PubMed ID: 26547915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis.
    Brueckmann M; Huhle G; Lang S; Haase KK; Bertsch T; Weiss C; Kaden JJ; Putensen C; Borggrefe M; Hoffmann U
    Circulation; 2005 Jul; 112(4):527-34. PubMed ID: 16027260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natriuretic peptide fragments as possible biochemical markers of hypertension in the elderly.
    Cappellin E; Gatti R; Antonelli G; Soldà G; Ragazzi E; De Palo EF; Spinella P
    J Cardiovasc Med (Hagerstown); 2013 Apr; 14(4):308-13. PubMed ID: 22498997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.